Titre : Bases de données pharmaceutiques

Bases de données pharmaceutiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Workforce
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Bases de données pharmaceutiques : Questions médicales les plus fréquentes", "headline": "Bases de données pharmaceutiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Bases de données pharmaceutiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-05", "dateModified": "2025-04-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Bases de données pharmaceutiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Bases de données factuelles", "url": "https://questionsmedicales.fr/mesh/D016208", "about": { "@type": "MedicalCondition", "name": "Bases de données factuelles", "code": { "@type": "MedicalCode", "code": "D016208", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "L01.470.750.750" } } }, "about": { "@type": "MedicalCondition", "name": "Bases de données pharmaceutiques", "alternateName": "Databases, Pharmaceutical", "code": { "@type": "MedicalCode", "code": "D062313", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michele B Kaufman", "url": "https://questionsmedicales.fr/author/Michele%20B%20Kaufman", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Konstantinos Vezertzis", "url": "https://questionsmedicales.fr/author/Konstantinos%20Vezertzis", "affiliation": { "@type": "Organization", "name": "School of Electrical and Computer Engineering, Biomedical Engineering Laboratory, National Technical University of Athens, Heroon Polytecniou 9, Athens, 15780, Athens, Greece." } }, { "@type": "Person", "name": "George I Lambrou", "url": "https://questionsmedicales.fr/author/George%20I%20Lambrou", "affiliation": { "@type": "Organization", "name": "School of Electrical and Computer Engineering, Biomedical Engineering Laboratory, National Technical University of Athens, Heroon Polytecniou 9, Athens, 15780, Athens, Greece." } }, { "@type": "Person", "name": "Dimitrios Koutsouris", "url": "https://questionsmedicales.fr/author/Dimitrios%20Koutsouris", "affiliation": { "@type": "Organization", "name": "School of Electrical and Computer Engineering, Biomedical Engineering Laboratory, National Technical University of Athens, Heroon Polytecniou 9, Athens, 15780, Athens, Greece." } }, { "@type": "Person", "name": "Piotr Ozieranski", "url": "https://questionsmedicales.fr/author/Piotr%20Ozieranski", "affiliation": { "@type": "Organization", "name": "Department of Social and Policy Sciences, University of Bath, Bath, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Profile of the Oncology Physician Workforce and the Characteristics of Attrition.", "datePublished": "2023-05-15", "url": "https://questionsmedicales.fr/article/37186885", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1200/OP.22.00830" } }, { "@type": "ScholarlyArticle", "name": "A national survey of the radiotherapy dosimetrist workforce in the UK.", "datePublished": "2022-09-26", "url": "https://questionsmedicales.fr/article/36063424", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1259/bjr.20220459" } }, { "@type": "ScholarlyArticle", "name": "Telebehavioral Health: Workforce, Access, and Future Implications.", "datePublished": "2022-05-14", "url": "https://questionsmedicales.fr/article/35680247", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.psc.2022.03.008" } }, { "@type": "ScholarlyArticle", "name": "Impact of federalization for health financing and workforce in Nepal.", "datePublished": "2023-06-08", "url": "https://questionsmedicales.fr/article/37291678", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s41256-023-00304-3" } }, { "@type": "ScholarlyArticle", "name": "Steps toward a resilient future nurse workforce.", "datePublished": "2023-04-14", "url": "https://questionsmedicales.fr/article/37053471", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1515/ijnes-2022-0057" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Sciences de l'information", "item": "https://questionsmedicales.fr/mesh/D007254" }, { "@type": "ListItem", "position": 3, "name": "Mémorisation et recherche des informations", "item": "https://questionsmedicales.fr/mesh/D016247" }, { "@type": "ListItem", "position": 4, "name": "Bases de données comme sujet", "item": "https://questionsmedicales.fr/mesh/D019992" }, { "@type": "ListItem", "position": 5, "name": "Bases de données factuelles", "item": "https://questionsmedicales.fr/mesh/D016208" }, { "@type": "ListItem", "position": 6, "name": "Bases de données pharmaceutiques", "item": "https://questionsmedicales.fr/mesh/D062313" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Bases de données pharmaceutiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Bases de données pharmaceutiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Bases de données pharmaceutiques", "description": "Comment identifier un médicament dans une base de données ?\nQuelles informations sont disponibles sur les effets secondaires ?\nComment vérifier les interactions médicamenteuses ?\nPeut-on trouver des informations sur les médicaments génériques ?\nComment évaluer l'efficacité d'un médicament ?", "url": "https://questionsmedicales.fr/mesh/D062313?mesh_terms=Workforce&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Bases de données pharmaceutiques", "description": "Où trouver des informations sur les symptômes liés à un médicament ?\nComment les symptômes sont-ils classés dans les bases ?\nLes bases fournissent-elles des exemples de symptômes ?\nComment les symptômes sont-ils liés aux médicaments ?\nPeut-on trouver des symptômes rares dans les bases ?", "url": "https://questionsmedicales.fr/mesh/D062313?mesh_terms=Workforce&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Bases de données pharmaceutiques", "description": "Les bases fournissent-elles des conseils de prévention ?\nComment prévenir les interactions médicamenteuses ?\nY a-t-il des recommandations pour les populations à risque ?\nComment les bases aident-elles à la prévention des maladies ?\nPeut-on trouver des stratégies de prévention dans les bases ?", "url": "https://questionsmedicales.fr/mesh/D062313?mesh_terms=Workforce&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Bases de données pharmaceutiques", "description": "Comment rechercher des traitements dans une base de données ?\nLes bases incluent-elles des protocoles de traitement ?\nComment comparer l'efficacité de différents traitements ?\nPeut-on trouver des alternatives aux traitements ?\nComment les traitements sont-ils mis à jour dans les bases ?", "url": "https://questionsmedicales.fr/mesh/D062313?mesh_terms=Workforce&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Bases de données pharmaceutiques", "description": "Comment identifier les complications liées à un médicament ?\nLes bases fournissent-elles des études de cas sur les complications ?\nComment les complications sont-elles signalées dans les bases ?\nPeut-on trouver des statistiques sur les complications ?\nComment prévenir les complications médicamenteuses ?", "url": "https://questionsmedicales.fr/mesh/D062313?mesh_terms=Workforce&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Bases de données pharmaceutiques", "description": "Quels facteurs de risque sont associés aux médicaments ?\nComment les bases évaluent-elles les facteurs de risque ?\nPeut-on trouver des recommandations sur les facteurs de risque ?\nComment les facteurs de risque influencent-ils le traitement ?\nLes bases incluent-elles des informations sur les facteurs de risque environnementaux ?", "url": "https://questionsmedicales.fr/mesh/D062313?mesh_terms=Workforce&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un médicament dans une base de données ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez le nom commercial, le principe actif ou le code ATC pour rechercher." } }, { "@type": "Question", "name": "Quelles informations sont disponibles sur les effets secondaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les bases fournissent des listes d'effets indésirables et leur fréquence." } }, { "@type": "Question", "name": "Comment vérifier les interactions médicamenteuses ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Consultez les sections dédiées aux interactions dans les bases de données." } }, { "@type": "Question", "name": "Peut-on trouver des informations sur les médicaments génériques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases de données incluent des informations sur les équivalents génériques." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un médicament ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Recherchez des études cliniques et des revues systématiques dans les bases." } }, { "@type": "Question", "name": "Où trouver des informations sur les symptômes liés à un médicament ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les bases de données listent les symptômes associés aux effets secondaires." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils classés dans les bases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont souvent classés par système corporel ou par fréquence d'apparition." } }, { "@type": "Question", "name": "Les bases fournissent-elles des exemples de symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles incluent des exemples pour chaque médicament et ses effets." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils liés aux médicaments ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les bases établissent des liens entre médicaments et symptômes rapportés." } }, { "@type": "Question", "name": "Peut-on trouver des symptômes rares dans les bases ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases documentent également des effets indésirables rares." } }, { "@type": "Question", "name": "Les bases fournissent-elles des conseils de prévention ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles incluent des recommandations pour éviter les effets indésirables." } }, { "@type": "Question", "name": "Comment prévenir les interactions médicamenteuses ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Consultez les bases pour identifier les médicaments à éviter ensemble." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour les populations à risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases fournissent des conseils spécifiques pour les groupes vulnérables." } }, { "@type": "Question", "name": "Comment les bases aident-elles à la prévention des maladies ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elles offrent des informations sur les médicaments préventifs et leur utilisation." } }, { "@type": "Question", "name": "Peut-on trouver des stratégies de prévention dans les bases ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles incluent des stratégies basées sur des données probantes pour la prévention." } }, { "@type": "Question", "name": "Comment rechercher des traitements dans une base de données ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des mots-clés comme le nom du médicament ou la pathologie traitée." } }, { "@type": "Question", "name": "Les bases incluent-elles des protocoles de traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles fournissent des recommandations et des protocoles basés sur des preuves." } }, { "@type": "Question", "name": "Comment comparer l'efficacité de différents traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Consultez les études comparatives et les méta-analyses disponibles." } }, { "@type": "Question", "name": "Peut-on trouver des alternatives aux traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases proposent souvent des alternatives thérapeutiques." } }, { "@type": "Question", "name": "Comment les traitements sont-ils mis à jour dans les bases ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les bases sont régulièrement mises à jour avec les dernières recherches et recommandations." } }, { "@type": "Question", "name": "Comment identifier les complications liées à un médicament ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les bases de données listent les complications possibles et leur fréquence." } }, { "@type": "Question", "name": "Les bases fournissent-elles des études de cas sur les complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles incluent des études de cas documentant des complications spécifiques." } }, { "@type": "Question", "name": "Comment les complications sont-elles signalées dans les bases ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont souvent signalées par des professionnels de santé et des patients." } }, { "@type": "Question", "name": "Peut-on trouver des statistiques sur les complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases fournissent des données statistiques sur la fréquence des complications." } }, { "@type": "Question", "name": "Comment prévenir les complications médicamenteuses ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les bases offrent des recommandations pour minimiser les risques de complications." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés aux médicaments ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les bases identifient des facteurs comme l'âge, le sexe et les comorbidités." } }, { "@type": "Question", "name": "Comment les bases évaluent-elles les facteurs de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Elles utilisent des études épidémiologiques et des données cliniques pour évaluer." } }, { "@type": "Question", "name": "Peut-on trouver des recommandations sur les facteurs de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases fournissent des recommandations pour gérer les facteurs de risque." } }, { "@type": "Question", "name": "Comment les facteurs de risque influencent-ils le traitement ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent modifier le choix du médicament et la posologie recommandée." } }, { "@type": "Question", "name": "Les bases incluent-elles des informations sur les facteurs de risque environnementaux ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent inclure des facteurs environnementaux influençant l'efficacité." } } ] } ] }

Sources (1683 au total)

Profile of the Oncology Physician Workforce and the Characteristics of Attrition.

To determine the prevalence of attrition and the frequency of transition from a primarily clinical role to an industry-related role among oncology physicians.... We tracked yearly Centers for Medicare & Medicaid Services (CMS) billing between 2015 and 2022 to estimate attrition of oncology physicians. A subanalysis of a random sample of 300 oncologists with fe... Of the 16,870 oncologists who billed to CMS in 2015, 3,558 (21%) had stopped billing by 2022. Among a randomly selected 300 oncologists, we found current employment information for 223 (74%); 78 of th... By 2022, 21% of oncology physicians billing to CMS in 2015 had stopped. 78 of the 300 sampled physicians were found to be working in industry. In total, 1 in 17 oncologists (5%) moved to industry over...

A national survey of the radiotherapy dosimetrist workforce in the UK.

To undertake a national survey of the Radiotherapy Dosimetrist workforce within the UK; examining different attributes and experiences, comparing results with published evidence within the literature.... A national, anonymised survey was undertaken between Dec 2020 and end of Feb 2021; employing a mixed-methods approach and blend of closed, open-ended answer choices and free-text comments. Questions i... A total of 223 individuals responded. Nearly half were trained via therapeutic radiography; approximately, a fifth through a clinical technologist/physics routes. Most (70%) had Dosimetrist in their j... Our survey showed a unique profile of the Radiotherapy Dosimetrist workforce in the UK, with a variety of training routes and statutory registration status. Nearly, a third were not engaged in a CPD s... A novel and unique national survey of Dosimetrists working in Radiotherapy in the UK is presented, leading to new insights into current training routes, registration status, job tasks and CPD engageme...

Steps toward a resilient future nurse workforce.

The psychosocial needs of nursing students are a pressing matter as mental health disorders may affect nursing students' journeys as professional nurses.... Psychological distress and burnout in nurses are threats to worldwide health care, as the stress associated with the COVID-19 pandemic could lead to an unstable future global nurse workforce.... Resiliency training can positively impact nurse stress, mindfulness, and resilience, as resilient nurses are better able to manage their response to stress and adversity which will contribute to posit... Educating faculty on resilience will aid nurse educators to create new student instructional approaches to improve mental health wellness.... Supportive faculty behaviors, self-care techniques, and resilience-building infused throughout the nursing curriculum may promote the effective transitioning of students into practice, providing the n...

Women's contribution to medicine in Bahrain: leadership and workforce.

Women make up a significant proportion of workforce in healthcare. However, they remain underrepresented in leadership positions relating to healthcare for a multitude of reasons: balancing personal a... Data were collected from the Bahraini Ministry of Health, National Health Regulatory Authority, Salmaniya Medical Complex, King Hamad University Hospital, Bahrain Defence Force Royal Medical Services,... The results of the study indicated that leadership positions were mostly held by males in Bahrain (59.4% vs. 40.6%). However, Bahraini males and females equally dominated academic positions. Male phys... This study highlights the increasing trend of women's participation and contribution to medicine in Bahrain. The data indicated continued growth in the number of female medical students and physicians...

CTC service heterogeneity and design of a workforce calculator.

To determine the level of heterogeneity in delivery of computed tomography (CT) colonography services and develop a workforce calculator that accommodates the variation identified.... A national survey, based on the "WHO workforce indicators of staffing need", established activity standards for essential tasks in delivery of the service. From these data a workforce calculator was d... Activity standards were established as mode responses >70%. Service homogeneity was greater in areas where professional standards and guidance were available. The mean service size was 1,101. Did not ... The survey identified benefits of radiographer-led direct booking and reporting. The workforce calculator derived from the survey provides a framework to guide the resourcing of expansion while mainta...

Update and projections for New Zealand's ophthalmology workforce.

The aim of this study was to update and project the growth of ophthalmologists in New Zealand. This will help decision makers better understand the current ophthalmologist workforce and make appropria... Supply and demographics of ophthalmologists in New Zealand were obtained from the Medical Council of New Zealand, Health Workforce New Zealand and Health New Zealand - Te Whatu Ora. Ophthalmology trai... In March 2023, there were 175 practising ophthalmologists in New Zealand. Overall, there were 34.0 ophthalmologists per million population, with 201.4 ophthalmologists per million for those aged ≥65 y... The ratio of ophthalmologists per million population aged ≥65 years is projected to drop by 1.5% annually. To meet the demand of an increasing and ageing population, and RANZCO's goal of 40 ophthalmol...